An increasing number of consumer brands are dedicating significant funds to scientific studies as a way to validate health and efficacy claims, aiming to inspire product advancements and enhance consumer confidence.
Scientific Support Gains Priority Over Promotional Spending
In categories like nutrition supplements and household cleaners, companies are shifting budgets away from traditional marketing tactics toward clinical research initiatives. Last year, AG1 debuted its upgraded supplement, AG1 NextGen, but only after completing four clinical trials to confirm benefits such as filling nutrient gaps and improving gut health. By September, AG1 revealed that it would allocate $20 million to further research over the following three years, focusing specifically on gut health and nutrition.
AG1 CEO Kat Cole noted that investing in clinical data allows the brand to build credibility and address misinformation, avoiding expensive mass-market ad campaigns like those at the Super Bowl. Such evidence helps attract discerning customers and provides defense during challenges to the brand’s health claims, according to Cole.
The Role of Clinical Evidence in Driving Brand Expansion
AG1’s model reflects what other successful brands are doing. Ritual, a vitamin company, has integrated clinical substantiation into its growth approach, committing at least $5 million to rigorous scientific studies and employing a research team equivalent to 20 full-time staff members. For CEO Katerina Schneider, being able to support claims with double-blind, placebo-controlled trials is a core point of distinction. This kind of evidence not only sets Ritual apart in a crowded space but also improves the effectiveness of their advertising and their sales results.
Research indicates that consumers value this approach. The 2024 Citruslabs survey showed that 85% of shoppers are influenced by science-backed product claims, underscoring the impact that substantiated messaging can have on both brand perception and retail partnerships.
How Scientific Research Informs Development and Differentiates Brands
Concrete research findings have directly affected the development of new products. For instance, AG1 applied insights from its clinical evaluation of NextGen to create the AG1 Essentials Gummies, ensuring the new offering addressed consumer needs discovered during research. Cole highlighted that having original studies positions AG1 as a leader and trusted resource for consumers seeking guidance on nutrition — far outpacing brands that make unverified or generic claims.
Companies must comply with Federal Trade Commission (FTC) guidelines, which require “competent and reliable scientific evidence” in health-related advertising, since there’s no strict FTC definition of “clinical” testing. Schneider says that just saying a product is clinically tested no longer satisfies informed customers or regulators, and she supports greater regulation in the supplement industry to protect consumers and ensure fair competition.
Peer-Reviewed Studies Offer Market Advantages
A growing number of brands are publishing their scientific results in reputable journals to enhance credibility. Ritual has conducted a minimum of five clinical trials, publishing three so far. One major publication appeared in Frontiers in Nutrition and addressed folate forms in prenatal supplements, while an additional study focused on the efficacy of their melatonin sleep aid. Their latest investigation, still pending publication, evaluated the impact of Ritual’s postnatal supplement on breast milk quality during a ten-week clinical trial involving 64 breastfeeding participants, measuring changes in human oligosaccharide prebiotic fiber (HMOs) and highlighted increases in this nutrient, which is often overlooked after childbirth.
These clinically backed studies do more than improve products — they help open doors in the retail sector. Thanks to its robust research, Ritual has expanded to over 6,000 stores, including Target, Costco, Whole Foods Market, and Ulta Beauty. Schneider emphasizes that in retail settings, providing documented scientific proof is critical for both getting listed and standing out among competitors.
Credibility Through Science in Emerging Sectors
The focus on scientific integrity is impacting more than just the supplement market. Blueland has positioned itself as a plastic-free brand and is nearing $500 million in lifetime sales; it holds more than 60 patents and maintains an in-house team of chemical scientists. Although Blueland hasn’t yet published peer-reviewed studies on its products, it did fund independent research featured in the International Journal of Environmental and Public Health, which concluded that plastic-coated laundry pods can release microplastics into waterways. This aligns with the company’s environmental mission and increases its appeal. Certifications from third parties, such as the EPA Safer Choice and Cradle2Cradle Material Health Certificate, further strengthen Blueland’s standing.
CEO Sarah Paiji Yoo believes that objective research and certification are pivotal in gaining consumer and retail trust. Today, Blueland items are stocked in more than 2,300 stores, including Target, Costco, and Kroger. Yoo explains that rigorous study results and external endorsements often determine whether retailers decide to carry a product.
Conclusion
With rising scrutiny from consumers and heightened competition on store shelves, brands are increasingly viewing clinical and scientific research as key assets for compliance, innovation, and expanded market presence. Establishing credibility through published studies and third-party certification is quickly becoming standard practice — signaling that evidence-backed science now holds as much weight for growth as classic advertising once did.